Botanical species · safety record

Ayapana triplinervis

The EFSA Compendium of Botanicals holds 8 constituent measurements for Ayapana triplinervis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ayapana triplinervis (Vahl) R.M.King & H.Rob.

8Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Also recorded as

Eupatorium triplinerve Vahl

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Ayapin	Aerial part of plants	Solvent extraction	—	Unspecified	No resolvable identifier
Coumarin	Leaves	Essential oil	2.5 Percent	Unspecified	No resolvable identifier
Herniarin	Leaves	Solvent extraction	0.5 Percent	Unspecified	No resolvable identifier
Herniarin	Leaves	Essential oil	—	Unspecified	No resolvable identifier
Myrcene	Leaves	Essential oil	1 Percent	Gaschromatography (GC)	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Thymoquinone	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Cheriyan, B.V., Venkatadri., Viswanathan., Kamalakannan. Screening of alcoholic extract of Eupatorium triplinerve Vahl and its fractions for its antinociceptive activity. Indian drugs, 2009, vol. 46, no. 10, p. 55-60.
Gupta, D., Charles, R., Garg, SN. Chemical composition of the essential oil from the leaves of Eupatorium triplinerve vahl . Journal of essential oil research, 2004, vol. 16, no. 5, p. 473-475.
Bose, Prafulla Kumar., Roy, Anil Chandra. The constitution of ayapanin. Journal of the indian chemical society, 1936, p. 586-587.
Bose, P. K., Sen, P. B. New hemostatic agents. I. Experiments with ayapanin and ayapin. Annals of biochemistry and experimental medicine, 1941, p. 311-316.
Garg, S. C., Nigam, Satgur S. Chemical examination of the essential oil from the leaves of Eupatorium triplinerve. Flavour industry, 1970, p. 469-472.
Nguyen thi Diem Trang., Wanner, M. J., Le Viet Ngoc Phuong., Koomen, G. J., Nguyen Xuan Dung. Thymoquinone from Eupatorium ayapana. Planta Medica, 1993.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature